期刊文献+

桥粒芯胶蛋白-1与头颈部鳞状细胞癌发生及预后相关性的研究 被引量:1

Desmocollin-1 significant correlated with the tumorigenesis and prognosis of HNSCC
原文传递
导出
摘要 目的:本研究拟探讨桥粒芯胶蛋白-1与头颈部鳞状细胞癌发生及预后的相关性。方法:本研究通过对NCBI数据库GEO获取的基因芯片数据进行统计学分析,并且采用头颈部鳞状细胞癌组织芯片予以验证。免疫组织化学的方法检测了组织芯片中芯胶蛋白-1的表达,并采用统计学方法分析了芯胶蛋白-1的表达与头颈部鳞状细胞癌发生、分化、预后等的相关性。结果:对GEO获取的芯片数据分析发现芯胶蛋白-1在头颈部鳞状细胞癌中表达增高,且表达增高的患者预后较差。组织芯片的验证实验显示结果与GEO数据库获取数据分析结果基本一致,在头颈部鳞状细胞癌中DSC1的表达显著高于正常组织,且在低分化头颈部鳞状细胞癌中表达高于高分化鳞状细胞癌。结论:桥粒芯胶蛋白-1的增高可促进头颈部鳞状细胞癌的发生,且与肿瘤分化相关。此外,其表达增高提示患者预后不良。 Objective:To explore the correlation between the expression of desmocollin-1and the tumorigenesis and prognosis of HNSCC.Method:Five datasets of HNSCC from the GEO were analyzed.A tumor tissue microassay was chosen for further test.The expression of DSC1 of TMA was detected by immunohistochemical staining.Result:The expression of DSC1 was significantly increased in HNSCC.Meanwhile,the expression of DSC1 was much higher in poor-differentiated tumor than the well-differentiated tumor in HNSCC.What's more,the HNSCC patients with lower expression of DSC1 had better outcomes.Conclusion:The results were according with the results of statistical analysis with the bioinformatics data from GEO,indicating that DSC1 significant correlated with the tumorigenesis and prognosis of HNSCC.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2016年第10期763-766,共4页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 国家自然科学基金(No:81372880) 教育部高校研究基金(No:20130141120093 20110141110062) 湖北省自然科学基金(No:012FFA045)
关键词 桥粒芯胶蛋白-1 头颈部鳞状细胞癌 预后 组织芯片 NCBI数据库 desmocollin-1 HNSCC prognosis tissue microassay NCBI database
  • 相关文献

参考文献15

  • 1GETSIOS S,AMARGO E V,DUSEK R L,et al.Coordinated expression of desmoglein 1and desmocollin1regulates intercellular adhesion[J].Differentiation,2004,72:419-433.
  • 2STAHLEY S N,KOWALCZYK A P.Desmosomes in acquired disease[J].Cell Tissue Res,2015,360:439-456.
  • 3李荣雪,王青釭.桥粒胶糖蛋白在肿瘤中的研究进展[J].临床和实验医学杂志,2015,14(18):1572-1574. 被引量:1
  • 4XIN Z,YAMAGUCHI A,SAKAMOTO K.Aberrant expression and altered cellular localization of desmosomal and hemidesmosomal proteins are associated with aggressive clinicopathological features of oral squamous cell carcinoma[J].Virchows Arch,2014,465:35-47.
  • 5AIZAWA S,OCHIAI T,ARA T,et al.Heterogeneous and abnormal localization of desmosomal proteins in oral intraepithelial neoplasms[J].J Oral Sci,2014,56:209-214.
  • 6KHAN K,HARDY R,HAQ A,et al.Desmocollin switching in colorectal cancer[J].Br J Cancer,2006,95:1367-1370.
  • 7SCHULE S,NEUHAUSER C,RAUCHFUSS F,et al.The influence of desmocollin 1-3expression on prognosis after curative resection of colorectal liver metastases[J].Int J Colorectal Dis,2014,29:9-14.
  • 8ON H R,HASHIMOTO T,KIM S C.Pemphigus herpetiformis with IgG autoantibodies to desmoglein 1and desmocollin 1[J].Br J Dermatol,2015,172:1144-1146.
  • 9BIZIKOVA P,DEAN G A,HASHIMOTO T,et al.Cloning and establishment of canine desmocollin-1as a major autoantigen in canine pemphigus foliaceus[J].Vet Immunol Immunopathol,2012,149:197-207.
  • 10KNOSEL T,CHEN Y,HOTOVY S,et al.Loss of desmocollin 1-3and homeobox genes PITX1 and CDX2are associated with tumor progression and survival in colorectal carcinoma[J].Int J Colorectal Dis,2012,27:1391-1399.

二级参考文献20

  • 1Nekrasova O, Green KJ. Desmosome assembly and dynamics [ J ]. Trends Cell Biol,2013,23 ( 11 ) :537 - 546.
  • 2Awad MM, Calkins H, Judge DP. Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy [ J ]. Nat Clin Pract Cardiovasc Med, 2008,5 ( 5 ) : 258 - 267.
  • 3Spindler V, Heupel WM, Efthymiadis A, et al. Desmocollin 3 - media- ted binding is crucial for keratinocyte cohesion and is impaired in pem- phigus[ J]. J Biol Chem,2009,284(44) :30556 - 30564.
  • 4Xin Z, Yamaguchi A, Sakamoto K. Aberrant expression and altered cellular localization of desmosomal and hemidesmosomal proteins are as- sociated with aggressive clinicopathological features of oral squamous cell carcinoma[ J]. Virchows Arch,2014,465 ( 1 ) :35 -47.
  • 5Pan J, Chert Y, Mo C, et al. Association of DSC3 mRNA down - regu- lation in prostate cancer with promoter hypermethylation and poor prog- nosis[J]. PLoS One,2014,9(3) :e92815.
  • 6Hamidov Z, Altendorf- Hofmann A, Chen Y, et al. Reduced expres- sion of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal ad Pathol, 2011,64( 11 ) :990 -994.
  • 7Wang Q, Peng D, Zhu S, et al. Regulation of Desmocollin3 Expression by Promoter Hypermethylation is Associated with Advanced Esophageal Adenocarcinomas[ J]. J Cancer, 2014,5(6) :457 -464.
  • 8Knosel T, Chen Y, Hotovy S, et al. Loss of desmocollin 1 -3 and ho- meobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma[J]. Int J Colorectal Dis, 2012,27 ( 11 ) : 1391 - 1399.
  • 9Hayashi T, Sentani K, Oue'N, et al. Desmoco|lin 2 is a new immuno- histochemical marker indicative of squamous differentiation in urothelial carcinoma[J]. Histopathology,2011,59(4) :710 -721.
  • 10Cui T, Chen Y, Yang L, et al. Diagnostic and prognostic impact ofdesmocollins in human lung cancer[ J]. J Clin Pathol,2012,65 (12) : 1100 - 1106.

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部